Drug Makers New Targets for U.S. Fraud Inquiries, Report Says

December 16, 2010
The New York Times
By Duff Wilson

Four pharmaceutical companies paid more than half of the $19.8 billion in civil and criminal settlements the last 20 years for improper billings to federal and state governments, according to a report Thursday by Public Citizen’s Health Research Group.

“Step aside, defense industry, there’s a new defrauder in town,” the group said on its Web site with the release of a 35–page report. Read more

Also In The News

Tell Us Your Thoughts

How do you feel about having to pay more than everyone else for your medication? Tell us your story. **By filling out this form you are giving RxRights permission to use your comments to help build support for safe, affordable drug importation.**